glp 1 receptor agonist drugs How GLP-1 Agonists Evolved from Diabetes to Weight Loss Treatments GLP-1 Receptor Agonists | New
Description
Oral GLP-1 agonist drug candidates overcome the limitation of injectable therapy by providing a more patient-friendly, painless and convenient alternative
This report provides an in-depth analysis of the Pfizer Metsera transaction and the broader GLP-1 pipeline war, tracing the historical context, market dynamics, and technical details of GLP-1 (glucagon-like peptide-1) based therapies
doi: 10.1152/ajpregu.00163.2004
Chin Med J 2021
doi: 10.1007/s40265-015-0427-5 [DOI] [PubMed] [Google Scholar] 137
